COVID-19 VACCINE:

DNA

researcher:

Scancell + University of Nottingham + Nottingham Trent University

(UK)

vaccine type: DNA-based

Distribution updates

currently no distribution info

Human Testing updates (clinical trials)

PHASE 1

in definition (expecting to start Q1 2021)

Aug 28	Scientists at Nottingham's two leading universities have announced plans to begin clinical trials of Scancell's vaccine in Q1 2021 (by nottinghampost.com)
Apr 24	Scancell will initiate Phase 1 clinical trial in Q1 2021 subject to funding (by reuters.com)

Animal Testing updates (pre-clinical trials)

currently no pre-clinical trials info

early development updates

Dec 18	Scancell Holdings have finally selected their COVID-19 vaccine SN14 for further development and clinical trials (by scancell.co.uk)
Apr 24	Scancell in partnership with Nottingham Uni has started a vaccine research programme (by scancell.co.uk)